Litcius/Paper detail

A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non–Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)

Yoshimasa Shiraishi, Taiki Hakozaki, Shogo Nomura, Tomoko Kataoka, Kentaro Tanaka, Satoru Miura, Yuta Sekino, Masahiko Ando, Hidehito Horinouchi, Yuichiro Ohe, Isamu Okamoto

2021Clinical Lung Cancer32 citationsDOI

Topics & Concepts

MedicineNivolumabPembrolizumabIpilimumabLung cancerChemotherapyOncologyInternal medicinePlatinumPhases of clinical researchImmunotherapyCancerChemistryCatalysisBiochemistryCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisRadiomics and Machine Learning in Medical Imaging